作者:Yung-Tzung Huang、Brian S. J. Blagg
DOI:10.1021/jo062083t
日期:2007.5.1
The DNA gyrase inhibitor, novobiocin, was recently shown to inhibit Hsp90 via a previously unrecognized C-terminal ATP-binding site. Previous structure−activity relationship studies identified key moieties that appear important for Hsp90 inhibitory activity. In an effort to provide a more efficacious lead compound, a parallel library of noviosylated coumarin analogues was prepared.
最近发现,DNA促旋酶抑制剂novobiocin可通过以前无法识别的C端ATP结合位点抑制Hsp90。以前的结构活性关系研究确定了对Hsp90抑制活性似乎很重要的关键部分。为了提供更有效的先导化合物,制备了诺维磺化香豆素类似物的平行文库。